Venture-Backed Startups

0 investors

Biome Resources is a microbiome company that develops products including Kronobiotic, a precision probiotic aimed at improving sleep quality, and Biome360, a gut microbiome analysis kit for personalized nutrition and preventive health. It combines biochemists, data scientists, and engineers to offer microbiome testing and preventive health technology at accessible cost.

1 investor

0 investors

1 investor

BiomeBank develops living microbial therapeutics derived from human gut microbiome collections, targeting conditions such as ulcerative colitis with a pipeline spanning immunity, metabolism, neurology and oncology. The company builds co-cultured microbial ecosystem therapies using its CONSORTIOME platform.

1 investor

BioMech develops wireless, noninvasive motion sensors and analytics software (BioMech Lab and BioMech AI) that capture and stream three-dimensional motion in real time. Its platform serves healthcare, sports/wellness, and industrial markets to quantify and improve movement outcomes.

0 investors

BioMed Central is an academic publisher of open access, peer-reviewed scientific journals, including titles such as Algorithms for Molecular Biology covering bioinformatics and molecular biology research. It serves researchers and academics across biology, medicine, and related life-science fields.

1 investor

0 investors

1 investor

0 investors

Biomeme develops a mobile molecular testing platform that brings laboratory-grade PCR diagnostics to the point of need, serving clinical partners and organizations that need real-time detection of biological threats and diseases. The company operates a vertically integrated facility spanning biology, engineering, software, and manufacturing.

3 investors

Biomerica is a biomedical technology company that develops, manufactures, and markets in-vitro diagnostic and therapeutic products for screening and detecting chronic conditions, with a focus on gastrointestinal and inflammatory diseases such as IBS. Its diagnostics are used worldwide for early disease detection and guiding therapy.

0 investors

Biomerics is a contract development and manufacturing organization (CDMO) that produces interventional medical device components, including plastic parts and micro metal components for OEMs. It serves markets such as medical robotics, cardiovascular, and endoscopy, with facilities in Costa Rica, the Dominican Republic, and other global medical device hubs.

1 investor

bioMérieux develops in vitro diagnostic solutions for clinical laboratories and healthcare professionals, covering areas such as antimicrobial stewardship, sepsis, and infectious disease detection. It also provides diagnostics for food safety and quality and pharmaceutical quality control.

1 investor

BiomeSense builds an AI-enabled platform combining hardware (GutLab) and bioinformatics (MetaBiome) to continuously generate and analyze gut microbiome data. It serves scientists, institutions, and companies conducting clinical research on the microbiome for personalized biomarker discovery and product development.

5 investors

0 investors

0 investors

Biomia is a biotechnology company using biology, chemistry, and pharmacoengineering to develop a new generation of central nervous system (CNS) therapeutics. It focuses on drug discovery to address unmet patient needs.

1 investor

0 investors

Biomimetic develops a bioinspired green-laser nano-texturing process that adds anti-reflective, anti-glare, anti-fogging, and super-hydrophilic properties to glass and crystal surfaces without chemicals. Its Tettix-branded treatments work on borosilicate, soda-lime, alkali-aluminosilicate, and sapphire substrates, and the company coordinates the EU-funded EIC Transition project "GLASS".

1 investor

0 investors

Biomine Health is South Africa's microbiome testing and treatment company, providing personalized health insights based on microbiome analysis to help people understand and optimize their gut health. The company serves individuals seeking proactive health management through microbiome-based diagnostics and treatments.

1 investor

BioModAI provides an autonomous AI agent that designs molecular biology assays, primers, CRISPR guides, and DNA constructs for research and biotech teams. The agent runs real bioinformatics tools on actual genomic data and delivers publication-ready reports with full audit trails, typically within hours.

1 investor

biomodal develops a multi-modal genomic sequencing platform, including its 6-base sequencing and duet evoC products, that profiles epigenetic (5mC, 5hmC), genetic, and fragmentomics biomarkers from a single DNA sample. Its technology is applied to liquid biopsy workflows for applications such as cancer detection.

2 investors